Comerica Bank’s ARK Genomic Revolution ETF ARKG Stock Holding History

Comerica Bank’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$75.5K	Sell	2,606 -2,201	-46%	-$66.1K	﹤0.01%	2719
2025 Q3	$133K	Buy	4,807 +30	+0.6%	+$758	﹤0.01%	2499
2025 Q2	$116K	Buy	4,777 +505	+12%	+$11.1K	﹤0.01%	2536
2025 Q1	$88.7K	Sell	4,272 -195	-4%	-$4.9K	﹤0.01%	2618
2024 Q4	$105K	Buy	4,467 +328	+8%	+$8.07K	﹤0.01%	2558
2024 Q3	$106K	Buy	4,139 +34	+0.8%	+$866	﹤0.01%	2552
2024 Q2	$96.4K	Sell	4,105 -138	-3%	-$3.48K	﹤0.01%	2554
2024 Q1	$122K	Sell	4,243 -11,511	-73%	-$346K	﹤0.01%	2473
2023 Q4	$517K	Buy	15,754 +8,920	+131%	+$243K	﹤0.01%	1842
2023 Q3	$190K	Buy	+6,834	New	+$223K	﹤0.01%	2231

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Comerica Bank's ARKG Position: Q4 2025 in Review

Comerica Bank reduced its ARK Genomic Revolution ETF (ARKG) stake by 46% in Q4 2025, selling an estimated $66.1K and leaving 2,606 shares worth $75.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2719.

Comerica Bank first reported a position in ARKG in Q3 2023 and has held it in 10 quarters since. The position peaked at $517K in Q4 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

Comerica Bank held 2,606 shares of ARK Genomic Revolution ETF worth $75.5K as of Q4 2025.
Comerica Bank sold 2,201 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $66.1K.
ARK Genomic Revolution ETF made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2719 holding.
Comerica Bank first reported a position in ARK Genomic Revolution ETF in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's ARK Genomic Revolution ETF position peaked at $517K in Q4 2023.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.